Form 4: Quest Diagnostics SVP, Clinical Solutions, Karthik Kuppusamy, Sells Shares

Karthik Kuppusamy, SVP, Clinical Solutions at Quest Diagnostics, sold 1,775 shares of common stock at an average price of $156.9156 on October 28, 2024.

Summary

• On October 28, 2024, Karthik Kuppusamy, SVP, Clinical Solutions at Quest Diagnostics, sold 1,775 shares of common stock.
• The sale was executed at a weighted average price of $156.9156 per share, with individual trades ranging from $156.830 to $156.9156.
• Following the transaction, Kuppusamy directly owns 9,734 shares of Quest Diagnostics common stock.
• Kuppusamy also indirectly owns 358 shares through a trust and 1,564 shares through the company's 401(k) plan.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of an insider transaction. The sale itself doesn't inherently indicate positive or negative sentiment about the company's future.

Industry Context

This is a routine disclosure of an insider transaction and doesn't necessarily indicate a broader trend within the diagnostics industry.

Stakeholder Impact

• The sale of shares by a company executive could be perceived negatively by some shareholders, although it is a relatively small transaction.

Key Dates